Sfe Investment Counsel Laboratory Corp Of America Holdings Transaction History

Sfe Investment Counsel

$462 Million
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$209.01 - $232.56 $434,740 - $483,724	-2,080 Reduced 19.76%	8,447 $1.85 Million
Q4 2023 Jan 31, 2024	BUY	$197.69 - $227.29 $47,445 - $54,549	240 Added 2.33%	10,527 $2.39 Million
Q3 2023 Oct 24, 2023	SELL	$201.05 - $221.7 $89,668 - $98,878	-446 Reduced 4.16%	10,287 $2.07 Million
Q2 2023 Jul 24, 2023	SELL	$211.93 - $241.33 $39,418 - $44,887	-186 Reduced 1.7%	10,733 $2.59 Million
Q1 2023 May 08, 2023	SELL	$213.32 - $257.83 $76,795 - $92,818	-360 Reduced 3.19%	10,919 $2.51 Million
Q4 2022 Feb 09, 2023	SELL	$203.72 - $248.97 $342,249 - $418,269	-1,680 Reduced 12.96%	11,279 $2.65 Million
Q3 2022 Nov 14, 2022	BUY	$204.81 - $262.19 $24,986 - $31,987	122 Added 0.95%	12,959 $2.65 Million
Q2 2022 Aug 10, 2022	SELL	$213.86 - $277.87 $15,611 - $20,284	-73 Reduced 0.57%	12,837 $3.01 Million
Q1 2022 May 06, 2022	BUY	$259.82 - $298.18 $1.47 Million - $1.69 Million	5,652 Added 77.87%	12,910 $3.4 Million
Q4 2021 Feb 07, 2022	SELL	$271.6 - $314.21 $31,505 - $36,448	-116 Reduced 1.57%	7,258 $2.28 Million
Q3 2021 Nov 12, 2021	BUY	$274.82 - $308.34 $8,244 - $9,250	30 Added 0.41%	7,374 $2.08 Million
Q2 2021 Aug 10, 2021	SELL	$251.87 - $278.14 $54,152 - $59,800	-215 Reduced 2.84%	7,344 $2.03 Million
Q1 2021 Apr 30, 2021	BUY	$204.88 - $255.03 $154,684 - $192,547	755 Added 11.1%	7,559 $1.93 Million
Q4 2020 Feb 04, 2021	SELL	$186.91 - $214.42 $4,112 - $4,717	-22 Reduced 0.32%	6,804 $1.39 Million
Q3 2020 Nov 09, 2020	SELL	$167.03 - $201.3 $38,416 - $46,299	-230 Reduced 3.26%	6,826 $1.29 Million
Q2 2020 Aug 05, 2020	SELL	$113.31 - $182.44 $20,962 - $33,751	-185 Reduced 2.55%	7,056 $1.17 Million
Q1 2020 May 04, 2020	BUY	$104.32 - $195.28 $12,518 - $23,433	120 Added 1.69%	7,241 $915,000
Q4 2019 Jan 17, 2020	SELL	$163.48 - $173.61 $150,401 - $159,721	-920 Reduced 11.44%	7,121 $1.21 Million
Q3 2019 Oct 31, 2019	SELL	$159.77 - $178.1 $14,379 - $16,029	-90 Reduced 1.11%	8,041 $1.35 Million
Q2 2019 Jul 26, 2019	BUY	$144.16 - $172.9 $8,505 - $10,201	59 Added 0.73%	8,131 $1.41 Million
Q1 2019 May 08, 2019	SELL	$123.7 - $156.3 $178,622 - $225,697	-1,444 Reduced 15.17%	8,072 $1.24 Million
Q4 2018 Feb 07, 2019	SELL	$120.82 - $174.09 $748,117 - $1.08 Million	-6,192 Reduced 39.42%	9,516 $1.2 Million
Q3 2018 Oct 31, 2018	BUY	$167.67 - $188.27 $805,151 - $904,072	4,802 Added 44.03%	15,708 $2.73 Million
Q2 2018 Jul 30, 2018	BUY	$160.33 - $189.41 $260,375 - $307,601	1,624 Added 17.5%	10,906 $1.96 Million
Q1 2018 May 01, 2018	SELL	$161.53 - $178.11 $385,895 - $425,504	-2,389 Reduced 20.47%	9,282 $1.5 Million
Q4 2017 Feb 06, 2018	BUY	$147.99 - $163.95 $63,931 - $70,826	432 Added 3.84%	11,671 $1.86 Million
Q3 2017 Nov 01, 2017	BUY	$149.47 - $160.56 $1.68 Million - $1.8 Million	11,239	11,239 $1.7 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfe Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Sfe Investment Counsel with notifications on news.

Account